Literature DB >> 25448751

Vitamin D deficiency in pregnant women impairs regulatory T cell function.

A Vijayendra Chary1, R Hemalatha2, M Seshacharyulu1, M Vasudeva Murali3, D Jayaprakash4, B Dinesh Kumar5.   

Abstract

Regulatory T cells and IgE receptors (CD23 and CD21) on B cells were assessed in vitamin D deficient pregnant women. For this, 153 pregnant women were recruited from a government hospital and were categorized into three groups based on 25-hydroxyvitamin D3 (25(OH)D3) status. Regulatory T cell population (Treg cells) and CD23/CD21 expression on B cells were quantified by FACS ARIA II in maternal blood at third trimester; and the same parameters were evaluated in cord blood soon after delivery. In addition, TGF β and IL-10 were quantified in maternal and cord blood by using Milliplex kits. In a representative sample of eight women from each group (vitamin D sufficient, insufficient and deficient), placental tissues were processed for mRNA expressions of vitamin D receptor (VDR), retinoic acid receptor (RXR), vitamin D binding protein (VDBP) and vitamin D regulating enzymes. Of the 153 pregnant women, 18 were sufficient (≥30 ng/mL), 55 were insufficient (20-29 ng/mL) and 80 were deficient (≤19 ng/mL) for 25(OH)D3 status. The maternal blood Treg cell population (mean (%)± SE) was lower (p<0.05) in 25(OH)D3 deficient (0.2 ± 0.01) pregnant women compared to insufficient (0.34 ± 0.01) and sufficient (0.45 ± 0.02) pregnant women. Similarly, cord blood Treg cell population (mean (%)± SE) was also lower (p<0.05) in 25(OH)D3 deficient (0.63 ± 0.03) pregnant women when compared to insufficient (1.05 ± 0.04) and sufficient (1.75 ± 0.02) pregnant women. Mean (%) ± SE of B cells with CD23 and CD21 in maternal blood was higher (p<0.05) in 25(OH)D3 deficient pregnant women (0.35 ± 0.02; 1.65 ± 0.04) when compared to insufficient (0.22 ± 0.02; 0.55 ± 0.05) and sufficient (0.15 ± 0.02; 0.21 ± 0.01) pregnant women. Similarly, mean (%)± SE of B cell population with CD23 and CD21 in cord blood was also higher (p<0.05) in 25(OH)D3 deficient (0.41 ± 0.02; 1.2 ± 0.03) when compared to insufficient (0.32 ± 0.01; 0.6 ± 0.05) and sufficient (0.2 ± 0.01; 0.4 ± 0.02) pregnant women. Regulatory cytokines, TGF β and IL-10 were lower (p<0.05) in 25(OH)D3 insufficient and deficient subjects. In the placenta tissue of women with 25(OH)D3 deficiency, the regulatory T cell transcription factor FOXP3, vitamin D receptor (VDR) and retinoic acid receptor (RXR) expressions were downregulated. In contrast, CD23, CD21 and VDBP expressions were upregulated in 25(OH)D3 deficient and insufficient women. Vitamin D regulating enzymes (CYP24A1, CYP2R1 and CYP27B1) expression were also altered in women with 25(OH)D3 deficiency. The current study shows that impaired maternal 25(OH)D3 during pregnancy influences the spectrum of immune cells such as regulatory T cells and B cells with IgE receptors and this in turn may be linked to allergy and asthma in neonates.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD21; CD23; FOXP3; Pregnancy; Regulatory T cells; VDR; Vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25448751     DOI: 10.1016/j.jsbmb.2014.11.020

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

Review 1.  Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  Maternal and cord blood vitamin D status and childhood infection and allergic disease: a systematic review.

Authors:  David A Fried; Jane Rhyu; Karen Odato; Heather Blunt; Margaret R Karagas; Diane Gilbert-Diamond
Journal:  Nutr Rev       Date:  2016-04-15       Impact factor: 7.110

3.  The role of regulatory T cells in the regulation of upper airway inflammation.

Authors:  Charlie Palmer; Jennifer K Mulligan; Sarah E Smith; Carl Atkinson
Journal:  Am J Rhinol Allergy       Date:  2017-11-01       Impact factor: 2.300

4.  Women with Recurrent Miscarriage Have Decreased Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase by the Fetal-Maternal Interface.

Authors:  Li-Qin Wang; Xiao-Ting Yan; Chun-Fang Yan; Xin-Wen Zhang; Ling-Yun Hui; Mingzhan Xue; Xue-Wen Yu
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

5.  Dietary vitamin D3 supplementation protects laying hens against lipopolysaccharide-induced immunological stress.

Authors:  Yanqiang Geng; Qiugang Ma; Zhong Wang; Yuming Guo
Journal:  Nutr Metab (Lond)       Date:  2018-08-10       Impact factor: 4.169

6.  Dietary vitamin D3 deficiency exacerbates sinonasal inflammation and alters local 25(OH)D3 metabolism.

Authors:  Jennifer K Mulligan; Whitney N Pasquini; William W Carroll; Tucker Williamson; Nicholas Reaves; Kunal J Patel; Elliott Mappus; Rodney J Schlosser; Carl Atkinson
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

Review 7.  Vitamin D Effects on the Immune System from Periconception through Pregnancy.

Authors:  Bianca Schröder-Heurich; Clara Juliane Pacifica Springer; Frauke von Versen-Höynck
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

8.  Evaluation of 1,25(OH)2D3 Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene Expression in the PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss (URPL).

Authors:  Elham Abdollahi; Nafiseh Saghafi; Seyed Abdolrahim Rezaee; Maryam Rastin; Lida Jarahi; Vicki Clifton; Houshang Rafatpanah
Journal:  Iran Biomed J       Date:  2020-02-23

9.  Prenatal high-dose vitamin D3 supplementation has balanced effects on cord blood Th1 and Th2 responses.

Authors:  Evana Akhtar; Akhirunnesa Mily; Ahsanul Haq; Abdullah Al-Mahmud; Shams El-Arifeen; Abdullah Hel Baqui; Daniel E Roth; Rubhana Raqib
Journal:  Nutr J       Date:  2016-08-09       Impact factor: 3.271

10.  Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface.

Authors:  N Li; H M Wu; F Hang; Y S Zhang; M J Li
Journal:  Braz J Med Biol Res       Date:  2017-09-12       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.